The introduction of both pneumococcal conjugate vaccines (PCVs) and rotavirus vaccines (RVs) led to a significant reduction in hospital admissions for winter diarrhea and respiratory infections. Within <5 years post-vaccine introduction, hospital admissions dropped by 78% for rotavirus diarrhea and 46% for pneumonia.
Researchers compared clinical outcomes between patients receiving nafcillin and cefazolin for MSSA bacteremia, finding that cefazolin had similar treatment failure rates but fewer adverse events. The study suggests that cefazolin may be a cost-effective alternative to nafcillin due to lower costs.
The silicone vaginal ring delivers hydrophilic molecules like tenofovir and acyclovir for extended periods, preventing viral infections such as HIV-1, hepatitis B, and genital herpes. Preliminary results demonstrate its potential to prevent STIs in young women with high risk of exposure.
The Women's Antiretroviral Efficacy and Safety Study found that women receiving Stribild had a higher rate of HIV suppression compared to those on ritonavir-boosted atazanavir plus Truvada. No one on Stribild developed resistant mutations, in contrast to three women in the comparator group.
Researchers developed a DNA sequencing device that can detect bacteria and antibiotic resistance in urine samples four times faster than traditional methods. The new method allows for quicker treatment and better stewardship of diminishing antibiotic reserves.